The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

December 2020

Volume 16 Number 12

This month a look at the ISCHEMIA trial in relation to real-world practice as applied to patients from the START registry; the novel DynamX bioadaptor system with uncaging elements allowing remodelling of the vessel wall; a post-hoc analysis of low wall shear stress and device target lesion failure from the ABSORB III imaging study; an MDCT study of impaired coronary access following redo TAVI; virtual reality use in conscious sedation during TAVI; coronary stent implantation in the treatment of intracranial stenoses; pulmonary arterial pressure as an indication for ASD closure; renal flow reserve and other haemodynamic measurements to inform revascularisation strategies for renal artery stenosis, and more...

Highlights from this issue

ISCHEMIA criteria in the START registry
ISCHEMIA criteria in the START registry
De Luca L, Uguccioni M, Meessen J, Temporelli P, Tomai F, De Rosa F, Passamonti E, Formigli D, Riccio C, Gabrielli D, Colivicchi F, Gulizia M, Perna G
December 18, 2020
DOI: 10.4244/EIJ-D-20-00610
DynamX clinical study
DynamX clinical study
Verheye S, Vrolix M, Montorfano M, Zivelonghi C, Giannini F, Bedogni F, Dubois C, De Bruyne B, Costa R, Chamié D, de Ribamar Costa J, Kereiakes D, Abizaid A, Colombo A
December 18, 2020
DOI: 10.4244/EIJ-D-20-00763
Coronary access after redo TAVI
Coronary access after redo TAVI
Buzzatti N, Montorfano M, Romano V, De Backer O, Søndergaard L, Rosseel L, Maurovich-Horvat P, Karady J, Merkely B, Prendergast B, De Bonis M, Colombo A, Latib A
December 18, 2020
DOI: 10.4244/EIJ-D-20-00475

Coronary interventions